SGEN Financial Facts

Research and development: 50.77M
Net income (loss): -15.67M
See Full Income Statement

Additional paid-in capital: -1.83B
Total current assets: -860.04M
See Full Balance Sheet

Seattle Genetics Inc. (SGEN) Earnings

  |   Expand Research on SGEN
Next EPS Date 5/8/14 *Est. EPS Growth Rate -44.4% *Last Qtr.
Average EPS % Beat Rate +39.5% Revenue Growth Rate +90.7% *Last Qtr.
Average % Move 1-Wk after EPS +7.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/11/14 Q413 -$0.13-$0.24 +$0.11$67.4M$59.5M N/A -12.7% Details
11/5/13 Q313 -$0.19-$0.22 +$0.03$57.8M$57.79M N/A +3.5% Details
7/31/13 Q213 -$0.06-$0.19 +$0.13$73.6M$57.15M N/A -1.8% Details
5/7/13 Q113 -$0.14-$0.20 +$0.06$57.3M$53.72M N/A +12.4% Details
2/12/13 Q412 -$0.09-$0.11 +$0.02$35.35M$57.21M N/A +36.1% Details
11/7/12 Q312 -$0.12-$0.15 +$0.03$49.8M$52.66M N/A +62.6% Details
8/8/12 Q212 -$0.15-$0.15 $0.00$48.8M$50.33M N/A +66.7% Details
5/8/12 Q112 -$0.11-$0.12 +$0.01$48.2M$52.33M N/A +109.1% Details